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Abstract
Background: Canada is among the most prosperous nations in the world, yet the health and wellness outcomes
of Canadian children are surprisingly poor. There is some evidence to suggest that these poor health outcomes are
partly due to clinical practice variation, which can stem from failure to apply the best available research evidence
in clinical practice, otherwise known as knowledge translation (KT). Surprisingly, clinical practice variation, even for
common acute paediatric conditions, is pervasive. Clinical practice variation results in unnecessary medical
treatments, increased suffering, and increased healthcare costs. This study focuses on improving health outcomes
for common paediatric acute health concerns by evaluating strategies that improve KT and reduce clinical practice
variation.
Design/Methods: Using a multiple case study design, qualitative and quantitative data will be collected from four
emergency departments in western Canada. Data sources will include: pre- and post-implementation focus group
data from multidisciplinary healthcare professionals; individual interviews with the local champions, KT intervention
providers, and unit/site leaders/managers; Alberta Context Tool (ACT) survey data; and aggregated patient outcome
data. Qualitative and quantitative data will be systematically triangulated, and matrices will be built to do cross-
case comparison. Explanations will be built about the success or lack of success of the clinical practice guidelines
(CPG) and clinical pathways (CPs) uptake based upon the cross-case comparisons.
Significance: This study will generate new knowledge about the potential causal mechanisms and factors which
shape implementation. Future studies will track the impact of the CPG/CPs implementation on children’s health
outcome, and healthcare costs.
Background
Canada is among the most prosperous nations in the
world, yet when compared to other nations in the Orga-
nisation for Economic Co-operation and Development
(OECD), Canadian children’s health and wellness out-
comes are surprisingly poor [1]. Each year almost 25% of
Canada’s approximate 9,500,000 million children require
emergency acute healthcare resulting in considerable
financial and emotional costs for families and society.
Clinical practice variation, even for common acute child
health conditions, continues to be pervasive, despite gui-
dance from research evidence [2]. Poorer health out-
comes, unnecessary medical treatments and suffering,
and increased strain on the healthcare system are poten-
tial outcomes from practice variation. Strategies that
mobilize the use of research evidence to inform children’s
healthcare can reduce healthcare utilization [3-11] and
high hospitalization rates. Hospitalization accounts for
43% to 62% of healthcare expenditures [12-16] and
comes with inherent risks [17-19]. Reduction of undesir-
able practice variation has been a major focus of systema-
tic efforts to improve the quality of the healthcare system
[20]. Clinical practice guidelines (CPGs) and clinical
pathways (CPs) have been embraced as one strategy to
decrease clinical practice variation through providing the
best available research evidence in the form of optimal
care recommendations. However, current research high-
lights that strategies to put CPG/CPs in clinical practice * Correspondence: shannon.scott@ualberta.ca
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any medium, provided the original work is properly cited.have not resulted in uniform implementation rates across
sites.
Despite the billions annually spent globally and the hun-
dreds of millions spent in Canada [21] on high-quality
health research, research transfer is a slow and haphazard
process [22]. In fact, it often takes 10 to 20 years for
research findings to be ‘translated’ into conventional
healthcare delivery [23]. Regrettably, child healthcare set-
tings are not immune to the challenges of applying the
best available research evidence to clinical practice, also
known as knowledge translation (KT). The literature high-
lights that the effectiveness of KT interventions, such as
CPG/CPs, to facilitate the transfer of research into clinical
practice varies by condition, professional group, and con-
text; however, the processes and factors shaping the imple-
mentation processes are not well studied.
CPGs are systematically developed research-based
recommendations to assist health professional and patient
decisions about appropriate healthcare for specific clinical
circumstances [24,25]. While broadly similar to CPGs, CPs
differ by being more explicit about the sequence, timing,
and provision of interventions [26]. Pathways are usually
based on pre-existing CPGs and developed by a multidisci-
plinary team of healthcare providers from one health insti-
tution for use within that institution. Despite the
prevalence of CPs, few published studies have evaluated
their impact on professional practice patterns or clinical
outcomes [26].
While CPG/CPs are well-established tools to ensure
that the best available research evidence informs health-
care, purposeful KT interventions, such as educational
sessions and reminders, are required to implement or
ensure that the CPG/CPs get used. Studies that deter-
mine whether KT interventions (e.g., printed reminders,
interactive educational sessions, and local champions)
result in improved patient outcomes have been con-
ducted, but little has been published about the causal
mechanisms that facilitated CPG/CP use (the ‘how’)o r
the effect modifiers (factors) that shaped the process.
This would not be an issue if we expected uniform CPG/
CP implementation rates across different settings and
conditions that could then be generalized to practitioners
outside of a study area. However, current evidence sug-
gests variation in CPG/CPs implementation rates across
the study sites and by condition, professional group, and
context [27,28] seemingly occur because the causal
mechanisms of the interventions are modified in the pre-
sence of different barriers and facilitators (the effect
modifiers). Thus, studying the causal mechanisms and
effect modifiers at each study site is an imperative step to
understand how to design future CPGs/CP implementa-
tions with a more consistent effect [29] that can be custo-
mized to the attributes of the CPG/CP condition,
professional group, and context [30].
There is increasing recognition of the importance of
process evaluation studies alongside trials of complex
interventions, such as KT interventions that demand beha-
vior change [27,31] in complex environments [32,33].
These studies can: delineate the extent to which all inter-
vention components are implemented; outline the factors
that shaped the implementation process; assess the consis-
tency of intervention delivery across multiple sites; explain
positive, modest, and insignificant results’ and provide
important links to understand and improve interventions.
Process evaluation studies are comparable to measuring
intermediate endpoints in clinical trials to further under-
stand the biological basis of any observed effect [27]. The
published literature includes a wealth of studies about KT
interventions that have successful outcomes [28,34], how-
ever there are a limited number of studies that disentangle
the factors that facilitate or hinder successful outcomes,
characterize the failure to achieve success, or attempt to
document the steps involved in achieving successful CPG/
CP implementation [33]. To date, much of the KT
research has not explored the ‘black box’–that is, KT inter-
ventions (inputs) are tested and outcomes (outputs) are
measured, however there has been no examination of the
mediating factors and processes (in the box) that lead to
the outcomes.
A unique opportunity exists to develop new knowledge
to improve children’s health outcomes, as well as make
theoretical contributions to KT. A CP for paediatric gas-
troenteritis and a CPG for croup will be implemented in
15 emergency departments (EDs) and Urgent Care Cen-
tres (UCC) in western Canada. This mix of health settings
reflects the variation of settings in which children receive
healthcare. Each of the 15 sites will have a gastroenteritis
CP and a croup CPG implemented using evidence-based
KT strategies including printed materials, educational ses-
sions and champions [35-37]. The study proposed here
evaluates the implementation of the CPG/CP by examin-
ing the factors that shape the implementation process to
develop theory to explain the well established variation in
CPG/CP implementation.
Research questions
With this study, we intend to answer the following
research questions:
1. What are the causal mechanisms and effect modi-
fiers (factors) that shape the CPG/CP implementation
processes?
2. How do the causal mechanisms and effect modifiers
of the KT interventions shape CPG/CP implementation?
Specific objectives
Our objectives are:
1a. to assess dose received of each of the KT interven-
tions at each site and the differences in dose received
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fessionals, managers, KT intervention providers, and
local champions.
1b. to assess dose delivered, reach, and fidelity of each
the KT interventions.
1c. to assess the attributes of the CPG/CP, factors from
each context (effect modifiers) and extent (both of effort
and uptake) of CPG/CP implementation at each site.
2. to develop an explanatory theory of the effect modi-
fiers and causal mechanisms shaping the CPG/CP imple-
mentation in healthcare settings delivering care to
children using ‘pattern matching’ [38,39] techniques across
the study variables within four of the 15 study sites.
Theoretical framing
The Ottawa Model of Research Use [40] will be used to
frame the data collection and analysis for this study. This
model, derived from theories of change, is a comprehen-
sive, interdisciplinary framework of elements that affect
KT. The six elements in the model considered central to
KT are: the evidence-base of the innovation (CPG/CP);
potential adopters (those using the CPG/CP); practice
environment (context); interventions to transfer the inno-
vation (i.e., KT strategies); adoption of the innovation (use
of the CPG/CP); and outcomes (i.e. CPG/CP implementa-
tion rates, actual health outcomes).
Methods/design
A mixed method multiple case study research design
[39,41] will be used to systematically explore the simulta-
neous implementation of two research-based CPG/CPs in
four clinical sites. A ‘case’ for each study site will be devel-
oped. Case studies provide the needed depth and com-
plexity to develop theory to explain how the attributes of
the KT interventions interact with contextual elements
(effect modifiers) to ‘produce’ CPG/CP implementation
processes that shape patient and system outcomes. The
components to be assessed in the study are included in
Table 1.
Sampling
Settings and site selection
There are 15 sites implementing the CPG/CP; four imple-
mentation sites will be purposefully selected to reflect
both urban and rural healthcare centres. All health profes-
sionals in each study site will be invited to participate in
the focus group interviews and surveys.
Data types and collection
The following data types will be collected for each case
(study site): pre-and post-implementation focus group
data with representation from all relevant health profes-
sional groups (e.g. nurse, physicians, and allied health
professionals working in the ED); individual interviews
with the local champions, intervention providers and
managers of each study site; Alberta Context Tool (ACT)
[42] survey data from health professionals at each study
sites; survey data on the extent of CPG/CP use and KT
intervention effectiveness; and documentation on KT
intervention delivery. Furthermore aggregate patient and
system outcome data (e.g., hospitalization rates, length of
stay) will be used as additional data sources.
Data collection
Group and individual interviews Group interviews
(focus groups) are an efficient, cost-effective data collec-
tion method that provide opportunities to generate rich
data while also observing group dynamics and levels of
c o n s e n s u so nt o p i c s .F o c u sg r o u p sw i l li n c l u d ef o u rt o
six participants and will range from 60 to 90 minutes.
Depending on the study site, participants could include a
paediatrician and emergency physician, a nurse from the
ED and inpatient setting, a pharmacist, a nurse manager,
and a nurse educator. Two focus groups will be con-
ducted at each site both pre-implementation and post-
implementation (16 focus groups) to acknowledge the
power dynamics amongst the health professional groups.
Key informant selection will be done in collaboration
with the local champion at each site. Interview questions
will focus on: attributes of and experiences using the
CPG/CP; attributes of their work environment (context);
barriers to using the CPG/CP; perceptions of CPG/CP
implementation success; and perceptions of the utility of
the KT interventions.
The focus groups will be conducted by SDS, and the
project coordinator will record observations of the focus
group as field notes (descriptive written accounts of
events). A court reporter will be present at all focus groups
to do ‘real-time transcription.’ This method produces tran-
scripts of greater fidelity more rapidly, which prevents the
loss of important contextual information and provides a
more complete and accurate account of the proceedings
on which to base subsequent analysis [43]. Individual
interviews will also occur with: local champions at each
site (n = 4); the KT intervention providers (n = 3); and
clinical setting managers post-implementation (n = 4).
Survey data All health professionals working at the four
study sites will be invited to complete an on-line version
of the ACT one month following the initial delivery of
the KT interventions. The ACT measures organizational
context and research utilization behaviours through
assessing eight dimensions of context, including: culture,
leadership, evaluation, social capital, informal interac-
tions, formal interactions, structural and electronic
resources, and organizational slack. This tool has been
used with nurses, physicians, clinical specialists, allied
health professionals, and managers, and the dimensions
have internal reliability, ranging from 0.5 to 0.96 [44,45].
The survey takes approximately 20 minutes to complete
and it has been revised, pilot tested, and used with both
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Canadian healthcare settings [46]. Given the size of each
of these sites, and previous response rates from other stu-
dies we have conducted at these sites, we anticipate
approximately 30 completed surveys/site. In addition,
health professionals will be asked to complete 10 survey
questions to assess the attributes of the KT interventions
and extent of CPG/CP implementation.
KT intervention documentation The providers of the
KT interventions will be asked to complete a spread-
sheet to assess delivery and participation in the KT
interventions.
Data analysis A n a l y s i so ft h em u l t i p l ed a t as o u r c e sw i l l
require a combination of qualitative and quantitative
approaches.
Qualitative data analysis The 16 focus group and 11
individual interviews will yield a large quantity of com-
plex data. SDS will lead the qualitative (inductive) analy-
sis working with the project co-ordinator and a graduate
student. To monitor the progress of the interviews and
permit follow-up of ideas that emerge from the data, data
collection and analysis will proceed concurrently. The
inductive analysis will occur in three phases: coding, cate-
gorizing, and developing themes. First, all data will be
coded to facilitate analysis. The code word(s) will reflect
the essence of the data, leading to ease of recognition as
the number of code words increases. Codes will be opera-
tionally defined so that they can be consistently applied
throughout the data. Second, codes will be placed into
b r o a dc a t e g o r i e st h a tc o r r e s p o n dt ot h em a j o ru n i to f
analysis. As categories emerge, their theoretical proper-
ties will be defined. Comparisons between multiple cate-
gories will be carried out in order to locate similarities
and differences between them. Finally, to obtain a holistic
view of the data, categories will be synthesized into
themes. This process will be replicated for the qualitative
data for each ‘case.’ Data analysis will be managed using
the NVIVO software package.
Survey analysis All ACT data will be entered into Statis-
tical Package for Social Sciences (SPSS) version 18.0.
These data collected at the individual level will be aggre-
gated to the level of the clinical setting (case) by calculat-
ing group means. Descriptive statistics (frequencies) and
proportions will be first conducted. Parametric (ANOVA)
and nonparametric (Kruskal-Wallis test) will be used to
provide a robust comparison among the four cases (study
sites) in terms of each of the eight dimensions of context.
Quantitative data will be graphically displayed to reflect
the variation in the eight dimensions across the four sites.
Statistical results will be one evidence source for each case.
Data triangulation Data triangulation will occur
through an integrated approach where the qualitative
and quantitative data will be systematically juxtaposed by
case (study site) through matrices [38] to examine pat-
terns and differences (across-cases) in terms of delivery
of the KT intervention (e.g., reach, dose delivered, and
fidelity), effect modifiers such as context, and outcomes
(health professional survey scores on CPG/CP implemen-
tation, case aggregated patient outcomes). Next, detailed
case descriptions will be written on each of the four cases
(study sites). Throughout data triangulation, ‘pattern
matching’ will occur across the four sites’ data in order
to build theory explaining the CPG/CP implementation
process. The complementary use of qualitative and quan-
titative data lend to the development of rich, detailed and
credible findings [38,39].
Strategies to ensure study rigor To minimize potential
bias, the collection and initial coding and analysis of the
qualitative data will be supervised and conducted by SDS,
who is not implementing the CPG/CPs. The investigators
Table 1 Components to be assessed in the study
Component Definition Data collection Study
objective
Context Environment/setting where CPG/CP is occurring -ACT survey
-Pre/Post focus group data
1c
CPG/CP attributes Features of the CPG and CP -Post focus group data 1c
Reach (of KT interventions) Proportion of professionals that participates in each KT
intervention.
-Education session
attendance
-Local champion interviews
1b
Dose delivered (of KT
interventions)
Amount of intervention delivered -Intervention provider
interviews
1b
Dose received (of KT
interventions)
Extent participants engaged with the KT interventions -Post-focus group data
-KT intervention records
1a
Fidelity (of the KT interventions) Extent to which the interventions were delivered as planned -Intervention provider
interviews
-KT intervention records
1b
Implementation of the CPG/CP Extent to which the intervention has been implemented and
received
-CPG/CP use survey scores
-Outcome data on CPG/CP
use
1c
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be incorporated into the final stages of analysis as
debriefers to provide credibility to the case descriptions.
All methodological decisions and insights will be docu-
mented in an audit trail [47,48]. Throughout analysis,
memos (detailed written accounts of events and deci-
sions) will be written to document the analysis process
and facilitate the development of explanatory theory.
Coding will be done jointly by the qualitative analysis
team and consensus negotiated to ensure representative-
ness [47].
Ethics Ethical approval has been granted for this study.
Informed consent procedures will include seeking the par-
ticipants’ consent to be interviewed (interviews and focus
groups) and having the interview and/or focus group
audio taped and/or transcribed in ‘real time.’ All identify-
ing information from the interview and focus group tran-
scripts will be removed prior to data analysis. The court
reporter (focus groups) will also sign a confidentiality
agreement. All research data will be stored under double
lock and key for a period of seven years.
Knowledge translation
Decision-maker partnership and integrated KT To
ensure effective communication and involvement
between the research team and potential users and to
accelerate the capture of benefits from this study, a stra-
tegic partnership a multidisciplinary group of paediatric
clinicians, healthcare decision makers, and researchers
from across the province who are charged with optimiz-
ing child health outcomes in Alberta has been developed.
This will serve as the ideal environment to provide input
about study findings and to facilitate evidence-informed
policy making to improve children’s health outcomes.
Discussion
Systematically studying CPG/CP implementation pro-
cesses is integral to improving future child health and sys-
tem outcomes. This study will generate new knowledge
about the causal mechanisms and factors that shape the
implementation of CPG/CPs in health settings delivering
care to children. Further, this study will generate
new knowledge on how economies-of-scale can be lever-
aged through innovative sharing of KT interventions to
implement two CPG/CPs. This knowledge can then be
leveraged to inform and improve future CPG/CP imple-
mentation efforts. Most importantly, in order for CPG/CP
to be an effective approach to put the best research evi-
dence into clinical practice, it is essential that CPG/CP
implementation processes are systematically studied to
develop theory to explain implementation variation across
sites. The application of research findings in healthcare
interventions, services, and policy decisions is a strategic
value and a fundamental principle of many provincial and
national healthcare agencies, as well as an important
‘return-on-investment’ societal priority. The findings
developed through this research will be especially impor-
tant for health organizations because great priority has
been placed on the development and standardization of
CPs to facilitate equitable, seamless, and consistent access
to healthcare. Knowledge of the processes and factors
shaping CPG/CP implementation will provide needed gui-
dance to assist health system bodies as future research-
based pathways are developed and implemented.
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